Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $70.78 USD
Change Today -4.09 / -5.46%
Volume 494.8K
SAGE On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
OTC US
Berlin
As of 8:10 PM 06/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael A. Rogawski M.D., Ph.D.

Member of Scientific Advisory Board, Sage Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 37 board members in 3 different organizations across 3 different industries.

See Board Relationships
----

Background*

Dr. Michael A. Rogawski, M.D., Ph.D. serves as a Professor and Chair of the Department of Neurology, University of California, Davis where, Dr. Rogawski leads a multidisciplinary research team focused on therapeutic strategies for epilepsy. He was senior investigator and chief of the Epilepsy Research Section at the National Institute of Neurological Disorders and Stroke, National Institutes of Health Until January 2007. He is an internationally recognized expert on ...

Read Full Background

Corporate Headquarters*

215 First Street
Cambridge, Massachusetts 02142

United States

Phone: 617-299-8380
Fax: 617-299-8379

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Yale University
MD
Yale University
BA
Amherst College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAGE:US $70.78 USD -4.09

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAGE THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.